,i #aahth ,,congress #ast ,session ,h4 ,r4 #djec ,,in ,,the ,,house ,,of ,,representatives ,june #ac1 #bjbc ,ms4 ,kuster 7for herself and ,mr4 ,carter of ,georgia7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on the ,judiciary1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to provide for the review of the scheduling under the ,controlled ,substances ,act of buprenorphine-naloxone combination products1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,studying ,suboxone ,act4 #b4 ,reviewing the scheduling of buprenorphine-naloxone combination products 7a7 ,secretary of ,,hhs ,the ,secretary of ,health and ,human ,services shall-- 7#a7 review and1 as appropriate1 update the scientific and medical evaluation conducted under section #bja7;b7 of the ,controlled ,substance ,act 7#ba ,u4,s4,c4 #haa7;b77 with respect to buprenorphine-naloxone combination products2 and 7#b7 update1 as necessary1 the ,secretary's scheduling recommendation under such section with respect to such products4 7b7 ,attorney ,general ,the ,attorney ,general shall-- 7#a7 review the recommendations provided by the ,secretary under subsection 7a71 and all other relevant data with respect to the scheduling of buprenorphine-naloxone combination products2 7#b7 consider the factors listed in subsection 7c7 of section #bja of the ,controlled ,substance ,act 7#ba ,u4,s4,c4 #haa7 with respect to such products2 and 7#c7 consistent with such section #bja1 make such scheduling changes with respect to such products as the ,secretary may determine appropriate4